Man with young onset Parkinson’s helps TV drama accurately portray condition Date 2 September 2022 add
Parkinson’s UK funding research into drug that could slow Parkinson’s progression Date 1 September 2022 The £2.9m phase 2 trial of a drug that could slow the progression of conditions like Parkinson's will be funded by the Parkinson's Virtual Biotech, our international drug discovery and development programme.
New ITV drama stars character with Parkinson’s Date 26 August 2022 Aidan Turner plays Doctor Joe O’Loughlin, who has just been diagnosed with Parkinson’s at 42, in new ITV series The Suspect.
£150,000 of grants awarded to physical activity and sports groups by Parkinson’s UK Date 25 August 2022 The grants will help activity providers deliver classes designed specifically for people with Parkinson’s.
Parkinson’s UK and Parkinson’s Foundation partner up to speed up the search for new treatments Date 23 August 2022 Over the next 3 years, the US-based Parkinson’s Foundation will invest a minimum of $3m (over £2.4m) into the Parkinson’s Virtual Biotech, our international drug discovery and development programme.
Disappointing results from trials of vaccines for Parkinson’s, but hope for the future Date 12 August 2022 2 clinical trials aiming to reduce the clumps of troublesome alpha-synuclein to protect brain cells have, so far, failed to show a clear benefit for people with Parkinson’s.
Cost of living support and what it means for the Parkinson's community Date 4 August 2022 A summary of the chancellor's cost of living support and what it means for people with Parkinson's.
Celebrating neuroscience in spring 2023 Date 4 August 2022 We are partnering with the British Neuroscience Association (BNA) to plan and deliver the BNA International Festival of Neuroscience 2023.
Work and Pensions Committee concerned about impact of the cost of living crisis on disabled people Date 27 July 2022 Parliament's Work and Pensions Committee have shared their concerns about the impact of the cost of living crisis on disabled people and urged government action to review the level of benefits.
